Influence of interleukin-1α and tumor necrosis factor-α production on corneal graft survival

Croatian Medical Journal

Volumn 47, Issue 1, 2006, Pages 59-66

  Bosnar, Damir ^a   Dekaris, Iva ^a   Gabrić, Nikica ^a   Markotić, Alemka ^b   Lazić, Ratimir ^a   Špoljarić, Ninoslav ^a  

^a Holy Ghost General Hospital   (Croatia)

^b INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; CORNEA TRANSPLANTATION; CYTOKINE RELEASE; DONOR; DYSTROPHY; FEMALE; FOLLOW UP; FREEZING; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INFLAMMATION; MALE; MEASUREMENT; RECIPIENT; CORNEA; MIDDLE AGED; PATHOPHYSIOLOGY; SECRETION;

ADULT; AGED; CORNEA; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644657198     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. de Vos AF, Klaren VN, Kijlstra A. Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci. 1994;35:3873-83.
2. Perez-Guijo V, Santos-Lacomba M, Sanchez-Hernandez M, Castro-Villegas Mdel C, Gallardo-Galera JM, Collantes-Estevez E. Tumour necrosis Factor-alpha levels in aqueous humour and serum from patients with uveitis: the involvement of HLA-B27. Curr Med Res Opin. 2004;20:155-7.
3. Yamagami S, Kawashima H, Endo H, Tsuru T, Shibui H, Kagawa Y, et al. Cytokine profiles of aqueous humor and graft in orthotopic mouse corneal transplantation. Transplantation. 1998;66:1504-10.
4. Zhu S, Dekaris I, Duncker G, Dana MR. Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation. J Interferon Cytokine Res. 1999;19:661-9.
5. Geiger KD, Sarvetnick NE. Ocular production of interferon-gamma and lack of major histocompatibility complex molecules induce immunological changes in the intraocular environment. Ger J Ophthalmol. 1996;5:309-14.
6. Okamoto S, Streilein JW. Role of inflammatory cytokines in induction of anterior chamber-associated immune deviation. Ocul Immunol Inflamm. 1998;6:1-11.
7. Balkwill FR, Burke F. The cytokine network. Immunol Today. 1989;10:299-304.
8. Barker CF, Billingham RE. Adv Immunol. 1977;25:1-54.
9. Streilein JW, Wilbanks GA, Cousins SW. Immunoregulatory mechanisms of the eye. J Neuroimmunol. 1992;39:185-200.
10. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990;48:191-226.
11. Streilein JW, Niederkorn JY. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med. 1981;153:1058-67.
12. Streilein JW, Cousins SW. Aqueous humor factors and their effect on the immune response in the anterior chamber. Curr Eye Res. 1990;9 Suppl:175-82.
13. Taylor AW, Streilein JW, Cousins SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res. 1992;11:1199-206.
14. Streilein JW, Bradley D, Sano Y, Sonoda Y. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest Ophthalmol Vis Sci. 1996;37:413-24.
15. Dekaris I, Gabric N, Mazuran R, Karaman Z, Mravicic I. Profile of cytokines in aqueous humor from corneal graft recipients. Croat Med J. 2001;42:650-6.
16. Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci. 1996;37:2485-94.
17. The Collaborative Corneal Transplantation Studies Research Group. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching, in high-risk corneal transplantation. Arch Ophthalmol. 1992;110:1392-403.
18. Streilein JW, Bradley D, Sano Y. Immune privilege in murine eye with abnormal corneas. In: The Association for Research in Vision and Ophthalmology Annual Meeting, Abstracts; 1994 May 1-6; Sarasota, Florida, USA. Invest Ophthalmol Vis Sci. 1994;35:1737.
19. Sano Y, Streilein JW. Effect of suture-induced corneal neovascularization on the ocular immunosuppressive microenvironment. In: Proceedings for the Third International Symposium on Recent Development in the Immunopathology and Intraocular Inflammation. Miami, Florida, Oct 10-14, 1993. Reg Immunol. 1994;6:173-6.
20. Dekaris I, Zhu SN, Dana MR. TNF-alpha regulates corneal Langerhans cell migration. J Immunol. 1999;162:4235-9.
21. Sano I, Takahashi T, Koji T, Udono H, Yui K, Ayabe H. Prolonged survival of rat cardiac allograft with proinflammatory cytokine inhibitor. J Heart Lung Transplant. 2001;20:583-9.
22. Roayaie S, Sheiner PA, Emre S, Guy S, Schwartz ME, Boros P, et al. Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients. Mediators Inflamm. 2000;9:141-6.
23. Torres PF, De Vos AF, van der Gaag R, Martins B, Kijlstra A. Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res. 1996;63:453-61.
24. Larkin DF, Calder VL, Lightman SL. Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection. Clin Exp Immunol. 1997;107:381-91.
25. Arancibia-Carcamo CV, Osawa H, Arnett HA, Haskova Z, George AJ, Ono SJ, et al. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous pep tides in immune-privileged sites. Eur J Immunol. 2004;34:471-80.
26. King WJ, Comer RM, Hudde T, Larkin DF, George AJ. Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation. 2000;70:1225-33.
27. Yamada J, Dana MR, Sotozono C, Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res. 2003;76:161-7.
28. Jie Y, Zhang WH, Pan ZQ, Wu YY, Wang Y. Interleukin-1 receptor antagonist eye drops promoting high-risk corneal allografts survival in rats. Chin Med J (Engl). 2004;117:711-6.
29. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation. 1997;63:1501-7.
30. Yamada J, Zhu SN, Streilein JW, Dana MR. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation. Invest Ophthalmol Vis Sci. 2000;41:4203-8.
31. Yamada J, Dana MR, Zhu SN, Alard P, Streilein JW. Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch Ophthalmol. 1998;116:1351-7.
32. Qian Y, Dekaris I, Yamagami S, Dana MR. Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants. Arch Ophthalmol. 2000;118:1666-71.
33. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Available at: http://www.wma.net/e/ policy/b3.htm. Accessed: November 23, 2005.
34. Williams KA, White MA, Ash JK, Coster DJ. Leukocytes in the graft bed associated with corneal graft failure. Analysis by immunohistology and actuarial graft survival. Ophthalmology. 1989;96:38-44.
35. Dana MR, Zhu SN, Yamada J. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea. 1998;17:403-9.
36. Coxon A, Bolon B, Estrada J, Kaufman S, Scully S, Rattan A, et al. Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis. Arthritis Rheum. 2002;46:2604-12.